EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clostridioides difficile clinical diagnostic test methods and results are associated with recovery of C. difficile by stool culture

Andrew M Skinner iD, Alice Y Guh, Laurica A Petrella, Susan Sambol, Adam Cheknis, Stuart Johnson iD, Christopher A Czaja, Helen Johnston, Elizabeth Basiliere, Robin A Dhonau, Lauren Korhonen, Ashley L Paulick iD und 4 weitere

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.03408-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Andrew M Skinner und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Section and Division of Infectious Diseases, VA Salt Lake City Health Care, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Feces, Diagnostic Tests, Routine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCEZID CDC HHS, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate molecular epidemiology relies on recovering Clostridioides difficile from clinical specimens and is essential for informing public health responses, characterizing strains that cause disease, and tracking strain prevalence. We performed a cross-sectional study of the recovery of C. difficile isolates from test-positive stools received January 2020 through December 2022 from the Colorado and Georgia Emerging Infections Program sites. Multivariable logistic regression models determined the adjusted odds ratio (aOR) and 95% confidence intervals (CIs) for factors which may influence C. difficile recovery in specimens that tested positive by either a dedicated or multiplex polymerase chain reaction (PCR) as part of either a reverse testing algorithm (PCR-positive, arbitrated by toxin enzyme immunoassay [EIA]) or a PCR-only testing protocol. Whole-genome sequencing was performed to determine the multilocus sequence types. C. difficile was recovered by culture from 84.3% (1,527/1,811) of all specimens. In specimens tested with a reverse testing algorithm, C. difficile culture recovery was less likely with multiplex versus dedicated PCR (aOR: 0.53; 95% CI: 0.34–0.85) and more likely in toxin EIA-positive versus toxin EIA-negative specimens (aOR: 8.07; 95% CI: 4.10–18.31). Recovery of C. difficile from stool cultures in PCR-only protocol cases was less likely when C. difficile was detected by multiplex PCR (aOR: 0.16; 95% CI: 0.03–0.55). ST1 was associated with toxin EIA-positive specimens, whereas ST2/110 was associated with toxin EIA-negative specimens. These findings can be used to maximize C. difficile surveillance programs, thereby enhancing the ability to generate robust molecular epidemiology data to inform prevention and control efforts. IMPORTANCE Public health surveillance of Clostridioides difficile is essential for tracking strains, understanding transmission, and informing public health strategies. The foundation of the surveillance is the successful recovery of C. difficile from clinical specimens for molecular typing. This study reveals that the choice of diagnostic test significantly impacts the ability to recover C. difficile by culture. These data reveal that culture recovery was lower from specimens that tested positive by syndromic multiplex polymerase chain reaction (PCR) panels compared to dedicated C. difficile PCR assays. Furthermore, recovery was more than eight times more likely from toxin enzyme immunoassay (EIA)-positive specimens than from toxin EIA-negative specimens, with high-virulence strains, such as PCR-ribotype 027, being associated with toxin EIA-positive results. These findings demonstrate that common diagnostic practices could introduce biases into surveillance data, potentially misrepresenting the true prevalence and epidemiology of clinically important strains. Understanding these factors is crucial for optimizing surveillance programs to generate accurate molecular epidemiologic data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsFecesDiagnostic Tests, RoutineHumansCross-Sectional StudiesMultiplex Polymerase Chain ReactionColoradoGeorgiaMolecular EpidemiologyPolymerase Chain ReactionMultilocus Sequence TypingBacterial Toxins

Stichwörter der Autor:innen

Clostridioides difficileclinical microbiologyepidemiology

Substanzen

Bacterial Toxins

Autor:innen und Institutionen

  • Research Section and Division of Infectious Diseases, VA Salt Lake City Health Care, Salt Lake City, Utah, USA.
  • Department of Medicine, Division of Infectious Diseases, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
  • Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Research Section, Edward Hines Jr., Veteran Affairs Hospital, Hines, Illinois, USA.
  • Colorado Department of Public Health and Environment, Denver, Colorado, USA.
  • Georgia Emerging Infections Program, Decatur, Georgia, USA.

ORCID-Profile: Andrew M Skinner, Stuart Johnson, Ashley L Paulick

Förderung

  • BLRD VA
  • NCEZID CDC HHS
  • U.S. Department of Veterans Affairs

Zitieren

APA

Skinner, A. M., Guh, A. Y., Petrella, L. A., Sambol, S., Cheknis, A., Johnson, S., Czaja, C. A., Johnston, H., Basiliere, E., Dhonau, R. A., Korhonen, L., Paulick, A. L., Samore, M. H., Adamczyk, M., Gargis, A. S., & Gerding, D. N. (2026). Clostridioides difficile clinical diagnostic test methods and results are associated with recovery of C. difficile by stool culture. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03408-25

Vancouver

Skinner AM, Guh AY, Petrella LA, Sambol S, Cheknis A, Johnson S, et al. Clostridioides difficile clinical diagnostic test methods and results are associated with recovery of C. difficile by stool culture. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03408-25

BibTeX
@article{Skinner2026,
  author = {Skinner, Andrew M and Guh, Alice Y and Petrella, Laurica A and Sambol, Susan and Cheknis, Adam and Johnson, Stuart and Czaja, Christopher A and Johnston, Helen and Basiliere, Elizabeth and Dhonau, Robin A and Korhonen, Lauren and Paulick, Ashley L and Samore, Matthew H and Adamczyk, Michelle and Gargis, Amy S and Gerding, Dale N},
  title = {Clostridioides difficile clinical diagnostic test methods and results are associated with recovery of C. difficile by stool culture},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.03408-25}
}
Kostenlos starten →